Simplex Trading’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.3K Buy
+5,500
New +$66.9K ﹤0.01% 6086
2025
Q3
Sell
-100
Closed -$1K 9100
2025
Q2
$1K Hold
100
﹤0.01% 8261
2025
Q1
$2K Hold
100
﹤0.01% 7932
2024
Q4
$1K Sell
100
-100
-50% -$1.92K ﹤0.01% 8160
2024
Q3
$3K Buy
+200
New +$3.98K ﹤0.01% 7811
2024
Q1
Sell
-100
Closed -$1K 8866
2023
Q4
$1K Buy
+100
New +$1.99K ﹤0.01% 8436

Other funds holding BTAL

Simplex Trading's BTAL Position: Q2 2026 in Review

Simplex Trading increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 1,041% in Q2 2026, buying an estimated $113K and bringing the position to 10,151 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #5395.

Simplex Trading first reported a position in BTAL in Q4 2023 and has held it in 6 quarters since. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Simplex Trading held 10,151 shares of AGF US Market Neutral Anti-Beta Fund worth $113K as of Q2 2026.
  • Simplex Trading bought 9,261 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $113K.
  • AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5395 holding.
  • Simplex Trading first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2023 and has held it in 6 quarters since.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.